Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

U.S. prevalence of antinuclear antibodies has steadily risen, study finds

Publish date:: April 17, 2020

Key clinical point: The prevalence of ANA in the United States was 11.0% in 1988-1991 and 15.9% in 2011-2012.

Major finding: The prevalence of ANA in the United States has increased considerably in recent years.

Study details: A retrospective analysis of serum samples from 14,211 individuals age 12 years and older.

Disclosures: The study was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The authors reported having no disclosures.

Citation:

Dinse G et al. Arthritis Rheumatol. 2020 April 7. doi: 10.1002/ART.41214.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Rheumatology

Osteoporosis prevalence in PsA similar to general population,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Oral steroids plus PPIs increase osteoporotic fracture risk in RA patients,

Etanercept may not help some with suspected nonradiographic axial spondyloarthritis,